Tilray Brands, Inc.

TLRY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2018 FY2017 FY2016
Operating Activities
Net Income $-67.7M $-7.8M $-7.9M
Depreciation & Amortization $3.6M $1.9M $2.0M
Depreciation $3.4M $1.5M
Amortization $374.0K $549.0K
Stock-Based Compensation $21.0M $139.0K $94.0K
Net Cash from Operating Activities $-46.2M $-6.0M $-3.3M
Investing Activities
Capital Expenditures $50.2M $10.9M $488.0K
Business Acquisitions
Net Cash from Investing Activities $-98.6M $-11.8M $-1.0M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $631.0M $12.2M $10.9M
Net Change in Cash $484.9M $-5.2M $6.8M
Free Cash Flow $-96.4M $-16.9M $-3.8M
← Newer Page 2 of 2 Older →